Exploring New Antibiotics from Vanoxerine Analogues
Author Information
Author(s): Kingdon Alexander D. H., Adcock Holly V., Kasimati Eleni-Marina, Craven Philip, van Schaik Willem, Cox Liam R., Besra Gurdyal S.
Primary Institution: School of Biosciences, University of Birmingham
Hypothesis
Can vanoxerine analogues be effective antibacterial agents against mycobacteria?
Conclusion
The study identified a promising vanoxerine analogue that could lead to new treatments for tuberculosis.
Supporting Evidence
- Vanoxerine analogues were synthesized to explore their antibacterial properties.
- Compound 3 was identified as the most active analogue against mycobacteria.
- The analogues retained the ability to inhibit efflux in mycobacteria.
- The study suggests that the analogues may work by disrupting the membrane electric potential.
Takeaway
Scientists made new versions of a medicine called vanoxerine to see if they could help fight a bad germ that causes tuberculosis.
Methodology
Ten vanoxerine analogues were synthesized and tested against various mycobacterial strains to assess their antibacterial activity.
Limitations
The cytotoxicity of the analogues against human cells was not evaluated at the tested concentrations.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website